KR20190072445A - Vinegar with enhanced skin whitening effect using Aster scaber and Ficus carica and production method thereof - Google Patents
Vinegar with enhanced skin whitening effect using Aster scaber and Ficus carica and production method thereof Download PDFInfo
- Publication number
- KR20190072445A KR20190072445A KR1020180160518A KR20180160518A KR20190072445A KR 20190072445 A KR20190072445 A KR 20190072445A KR 1020180160518 A KR1020180160518 A KR 1020180160518A KR 20180160518 A KR20180160518 A KR 20180160518A KR 20190072445 A KR20190072445 A KR 20190072445A
- Authority
- KR
- South Korea
- Prior art keywords
- vinegar
- fermented
- skin whitening
- ethanol
- present
- Prior art date
Links
- 239000000052 vinegar Substances 0.000 title claims abstract description 64
- 235000021419 vinegar Nutrition 0.000 title claims abstract description 64
- 230000002087 whitening effect Effects 0.000 title claims abstract description 28
- 238000004519 manufacturing process Methods 0.000 title abstract description 23
- 235000005276 Doellingeria scabra Nutrition 0.000 title abstract description 5
- 241000527163 Aster scaber Species 0.000 title abstract 4
- 244000025361 Ficus carica Species 0.000 title 1
- 235000008730 Ficus carica Nutrition 0.000 title 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims abstract description 60
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims abstract description 36
- 239000000469 ethanolic extract Substances 0.000 claims abstract description 26
- 238000000034 method Methods 0.000 claims abstract description 15
- 241000894006 Bacteria Species 0.000 claims abstract description 8
- 240000004808 Saccharomyces cerevisiae Species 0.000 claims abstract description 8
- 235000014680 Saccharomyces cerevisiae Nutrition 0.000 claims abstract description 8
- 239000012141 concentrate Substances 0.000 claims abstract description 8
- 239000000203 mixture Substances 0.000 claims description 35
- XUMBMVFBXHLACL-UHFFFAOYSA-N Melanin Chemical compound O=C1C(=O)C(C2=CNC3=C(C(C(=O)C4=C32)=O)C)=C2C4=CNC2=C1C XUMBMVFBXHLACL-UHFFFAOYSA-N 0.000 claims description 28
- 239000002537 cosmetic Substances 0.000 claims description 14
- 239000000796 flavoring agent Substances 0.000 claims description 14
- 235000013376 functional food Nutrition 0.000 claims description 14
- 239000004480 active ingredient Substances 0.000 claims description 13
- 230000036541 health Effects 0.000 claims description 12
- 235000019634 flavors Nutrition 0.000 claims description 9
- 244000189548 Chrysanthemum x morifolium Species 0.000 claims description 8
- 241001454694 Clupeiformes Species 0.000 claims description 8
- 235000019513 anchovy Nutrition 0.000 claims description 8
- 239000000049 pigment Substances 0.000 claims description 7
- 235000007516 Chrysanthemum Nutrition 0.000 claims description 6
- 208000021710 Hyperpigmentation disease Diseases 0.000 claims description 4
- 235000009604 Chrysanthemum X morifolium Nutrition 0.000 claims description 3
- 238000000855 fermentation Methods 0.000 abstract description 8
- 230000004151 fermentation Effects 0.000 abstract description 8
- 210000003491 skin Anatomy 0.000 description 31
- 102000003425 Tyrosinase Human genes 0.000 description 18
- 108060008724 Tyrosinase Proteins 0.000 description 18
- 230000000694 effects Effects 0.000 description 13
- 239000000047 product Substances 0.000 description 13
- 238000002360 preparation method Methods 0.000 description 11
- 230000000052 comparative effect Effects 0.000 description 10
- 239000000284 extract Substances 0.000 description 10
- 235000013305 food Nutrition 0.000 description 10
- 238000009472 formulation Methods 0.000 description 8
- 230000008099 melanin synthesis Effects 0.000 description 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 8
- 102100031413 L-dopachrome tautomerase Human genes 0.000 description 7
- 208000003351 Melanosis Diseases 0.000 description 7
- -1 body cleanser Substances 0.000 description 7
- 108010051081 dopachrome isomerase Proteins 0.000 description 7
- 210000002752 melanocyte Anatomy 0.000 description 7
- 150000008442 polyphenolic compounds Chemical class 0.000 description 7
- 235000013824 polyphenols Nutrition 0.000 description 7
- 235000019640 taste Nutrition 0.000 description 7
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 6
- 230000003078 antioxidant effect Effects 0.000 description 6
- 150000001720 carbohydrates Chemical class 0.000 description 6
- 238000011156 evaluation Methods 0.000 description 6
- BJRNKVDFDLYUGJ-RMPHRYRLSA-N hydroquinone O-beta-D-glucopyranoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-RMPHRYRLSA-N 0.000 description 6
- 206010014970 Ephelides Diseases 0.000 description 5
- 208000012641 Pigmentation disease Diseases 0.000 description 5
- 210000004027 cell Anatomy 0.000 description 5
- 235000014113 dietary fatty acids Nutrition 0.000 description 5
- 239000000194 fatty acid Substances 0.000 description 5
- 229930195729 fatty acid Natural products 0.000 description 5
- 235000013355 food flavoring agent Nutrition 0.000 description 5
- 229940093915 gynecological organic acid Drugs 0.000 description 5
- 230000006872 improvement Effects 0.000 description 5
- 239000004615 ingredient Substances 0.000 description 5
- 150000007524 organic acids Chemical class 0.000 description 5
- 235000005985 organic acids Nutrition 0.000 description 5
- 230000001953 sensory effect Effects 0.000 description 5
- 239000000243 solution Substances 0.000 description 5
- 102100030310 5,6-dihydroxyindole-2-carboxylic acid oxidase Human genes 0.000 description 4
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 4
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 4
- WTDRDQBEARUVNC-UHFFFAOYSA-N L-Dopa Natural products OC(=O)C(N)CC1=CC=C(O)C(O)=C1 WTDRDQBEARUVNC-UHFFFAOYSA-N 0.000 description 4
- MWUXSHHQAYIFBG-UHFFFAOYSA-N Nitric oxide Chemical compound O=[N] MWUXSHHQAYIFBG-UHFFFAOYSA-N 0.000 description 4
- 150000001413 amino acids Chemical class 0.000 description 4
- 230000003796 beauty Effects 0.000 description 4
- 235000014633 carbohydrates Nutrition 0.000 description 4
- 238000006243 chemical reaction Methods 0.000 description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 4
- 238000000605 extraction Methods 0.000 description 4
- 230000002401 inhibitory effect Effects 0.000 description 4
- 108010014402 tyrosinase-related protein-1 Proteins 0.000 description 4
- DNIAPMSPPWPWGF-GSVOUGTGSA-N (R)-(-)-Propylene glycol Chemical compound C[C@@H](O)CO DNIAPMSPPWPWGF-GSVOUGTGSA-N 0.000 description 3
- YFTGOBNOJKXZJC-UHFFFAOYSA-N 5,6-dihydroxyindole-2-carboxylic acid Chemical compound OC1=C(O)C=C2NC(C(=O)O)=CC2=C1 YFTGOBNOJKXZJC-UHFFFAOYSA-N 0.000 description 3
- 241000196324 Embryophyta Species 0.000 description 3
- 102000004190 Enzymes Human genes 0.000 description 3
- 108090000790 Enzymes Proteins 0.000 description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- 206010061218 Inflammation Diseases 0.000 description 3
- WTDRDQBEARUVNC-LURJTMIESA-N L-DOPA Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C(O)=C1 WTDRDQBEARUVNC-LURJTMIESA-N 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 3
- 230000009471 action Effects 0.000 description 3
- 229960000271 arbutin Drugs 0.000 description 3
- 239000006071 cream Substances 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 235000011194 food seasoning agent Nutrition 0.000 description 3
- 239000003205 fragrance Substances 0.000 description 3
- 229940088597 hormone Drugs 0.000 description 3
- 239000005556 hormone Substances 0.000 description 3
- 230000004054 inflammatory process Effects 0.000 description 3
- BEJNERDRQOWKJM-UHFFFAOYSA-N kojic acid Chemical compound OCC1=CC(=O)C(O)=CO1 BEJNERDRQOWKJM-UHFFFAOYSA-N 0.000 description 3
- WZNJWVWKTVETCG-UHFFFAOYSA-N kojic acid Natural products OC(=O)C(N)CN1C=CC(=O)C(O)=C1 WZNJWVWKTVETCG-UHFFFAOYSA-N 0.000 description 3
- 229960004705 kojic acid Drugs 0.000 description 3
- 239000006210 lotion Substances 0.000 description 3
- 235000015097 nutrients Nutrition 0.000 description 3
- BJRNKVDFDLYUGJ-UHFFFAOYSA-N p-hydroxyphenyl beta-D-alloside Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-UHFFFAOYSA-N 0.000 description 3
- 230000019612 pigmentation Effects 0.000 description 3
- 239000000843 powder Substances 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 239000002994 raw material Substances 0.000 description 3
- 239000000523 sample Substances 0.000 description 3
- 239000002904 solvent Substances 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 229930003231 vitamin Natural products 0.000 description 3
- 235000013343 vitamin Nutrition 0.000 description 3
- 239000011782 vitamin Substances 0.000 description 3
- 229940088594 vitamin Drugs 0.000 description 3
- 241000589234 Acetobacter sp. Species 0.000 description 2
- BPYKTIZUTYGOLE-IFADSCNNSA-N Bilirubin Chemical compound N1C(=O)C(C)=C(C=C)\C1=C\C1=C(C)C(CCC(O)=O)=C(CC2=C(C(C)=C(\C=C/3C(=C(C=C)C(=O)N\3)C)N2)CCC(O)=O)N1 BPYKTIZUTYGOLE-IFADSCNNSA-N 0.000 description 2
- 206010008570 Chloasma Diseases 0.000 description 2
- VYZAMTAEIAYCRO-UHFFFAOYSA-N Chromium Chemical compound [Cr] VYZAMTAEIAYCRO-UHFFFAOYSA-N 0.000 description 2
- 240000005250 Chrysanthemum indicum Species 0.000 description 2
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 2
- LCGLNKUTAGEVQW-UHFFFAOYSA-N Dimethyl ether Chemical compound COC LCGLNKUTAGEVQW-UHFFFAOYSA-N 0.000 description 2
- 239000004278 EU approved seasoning Substances 0.000 description 2
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 2
- NTYJJOPFIAHURM-UHFFFAOYSA-N Histamine Chemical compound NCCC1=CN=CN1 NTYJJOPFIAHURM-UHFFFAOYSA-N 0.000 description 2
- QIGBRXMKCJKVMJ-UHFFFAOYSA-N Hydroquinone Chemical compound OC1=CC=C(O)C=C1 QIGBRXMKCJKVMJ-UHFFFAOYSA-N 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- 208000005374 Poisoning Diseases 0.000 description 2
- 239000002202 Polyethylene glycol Substances 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- 229920002472 Starch Polymers 0.000 description 2
- 238000002835 absorbance Methods 0.000 description 2
- 230000002378 acidificating effect Effects 0.000 description 2
- 239000000440 bentonite Substances 0.000 description 2
- 229910000278 bentonite Inorganic materials 0.000 description 2
- SVPXDRXYRYOSEX-UHFFFAOYSA-N bentoquatam Chemical compound O.O=[Si]=O.O=[Al]O[Al]=O SVPXDRXYRYOSEX-UHFFFAOYSA-N 0.000 description 2
- SESFRYSPDFLNCH-UHFFFAOYSA-N benzyl benzoate Chemical compound C=1C=CC=CC=1C(=O)OCC1=CC=CC=C1 SESFRYSPDFLNCH-UHFFFAOYSA-N 0.000 description 2
- 235000013361 beverage Nutrition 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- 210000000988 bone and bone Anatomy 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 229910052804 chromium Inorganic materials 0.000 description 2
- 239000011651 chromium Substances 0.000 description 2
- 235000009508 confectionery Nutrition 0.000 description 2
- 238000001784 detoxification Methods 0.000 description 2
- MHUWZNTUIIFHAS-CLFAGFIQSA-N dioleoyl phosphatidic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCC(COP(O)(O)=O)OC(=O)CCCCCCC\C=C/CCCCCCCC MHUWZNTUIIFHAS-CLFAGFIQSA-N 0.000 description 2
- LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 230000001747 exhibiting effect Effects 0.000 description 2
- 239000003925 fat Substances 0.000 description 2
- 235000019197 fats Nutrition 0.000 description 2
- 150000004665 fatty acids Chemical class 0.000 description 2
- 235000021107 fermented food Nutrition 0.000 description 2
- 239000000835 fiber Substances 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- 230000002068 genetic effect Effects 0.000 description 2
- RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 description 2
- 235000011187 glycerol Nutrition 0.000 description 2
- 235000013402 health food Nutrition 0.000 description 2
- 208000000069 hyperpigmentation Diseases 0.000 description 2
- 230000003810 hyperpigmentation Effects 0.000 description 2
- 230000005764 inhibitory process Effects 0.000 description 2
- 229960004502 levodopa Drugs 0.000 description 2
- 210000002780 melanosome Anatomy 0.000 description 2
- 239000002953 phosphate buffered saline Substances 0.000 description 2
- 231100000572 poisoning Toxicity 0.000 description 2
- 230000000607 poisoning effect Effects 0.000 description 2
- 229920001223 polyethylene glycol Polymers 0.000 description 2
- 238000006116 polymerization reaction Methods 0.000 description 2
- 230000002265 prevention Effects 0.000 description 2
- 235000018102 proteins Nutrition 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- GHMLBKRAJCXXBS-UHFFFAOYSA-N resorcinol Chemical compound OC1=CC=CC(O)=C1 GHMLBKRAJCXXBS-UHFFFAOYSA-N 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 239000000600 sorbitol Substances 0.000 description 2
- 235000010356 sorbitol Nutrition 0.000 description 2
- 239000007921 spray Substances 0.000 description 2
- 235000019698 starch Nutrition 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- 150000003722 vitamin derivatives Chemical class 0.000 description 2
- JNYAEWCLZODPBN-JGWLITMVSA-N (2r,3r,4s)-2-[(1r)-1,2-dihydroxyethyl]oxolane-3,4-diol Chemical compound OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O JNYAEWCLZODPBN-JGWLITMVSA-N 0.000 description 1
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
- WNWHHMBRJJOGFJ-UHFFFAOYSA-N 16-methylheptadecan-1-ol Chemical class CC(C)CCCCCCCCCCCCCCCO WNWHHMBRJJOGFJ-UHFFFAOYSA-N 0.000 description 1
- XHSWVNQODRKABJ-UHFFFAOYSA-N 2,7-dinitroindazole Chemical compound [O-][N+](=O)C1=CC=CC2=CN([N+]([O-])=O)N=C12 XHSWVNQODRKABJ-UHFFFAOYSA-N 0.000 description 1
- HCXVJBMSMIARIN-ZETWWWAOSA-N 24alpha-Ethyl-koprostanol Natural products CC[C@H](C=C[C@H](C)[C@H]1CC[C@@H]2[C@H]3CC=C4C[C@@H](O)CC[C@]4(C)[C@@H]3CC[C@]12C)C(C)C HCXVJBMSMIARIN-ZETWWWAOSA-N 0.000 description 1
- GOLORTLGFDVFDW-UHFFFAOYSA-N 3-(1h-benzimidazol-2-yl)-7-(diethylamino)chromen-2-one Chemical compound C1=CC=C2NC(C3=CC4=CC=C(C=C4OC3=O)N(CC)CC)=NC2=C1 GOLORTLGFDVFDW-UHFFFAOYSA-N 0.000 description 1
- 208000004998 Abdominal Pain Diseases 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- 208000035285 Allergic Seasonal Rhinitis Diseases 0.000 description 1
- 206010003210 Arteriosclerosis Diseases 0.000 description 1
- 108010011485 Aspartame Proteins 0.000 description 1
- 241000208838 Asteraceae Species 0.000 description 1
- 241000416162 Astragalus gummifer Species 0.000 description 1
- 235000017166 Bambusa arundinacea Nutrition 0.000 description 1
- 235000017491 Bambusa tulda Nutrition 0.000 description 1
- 241001474374 Blennius Species 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 208000017667 Chronic Disease Diseases 0.000 description 1
- 235000018959 Chrysanthemum indicum Nutrition 0.000 description 1
- 241001672694 Citrus reticulata Species 0.000 description 1
- 208000002881 Colic Diseases 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- 208000034656 Contusions Diseases 0.000 description 1
- 229920000858 Cyclodextrin Polymers 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- KVSNMTUIMXZPLU-UHFFFAOYSA-N D:A-friedo-oleanane Natural products CC12CCC3(C)C4CC(C)(C)CCC4(C)CCC3(C)C2CCC2(C)C1CCCC2C KVSNMTUIMXZPLU-UHFFFAOYSA-N 0.000 description 1
- 241000238557 Decapoda Species 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- 239000004375 Dextrin Substances 0.000 description 1
- 229920001353 Dextrin Polymers 0.000 description 1
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 1
- AHMIDUVKSGCHAU-UHFFFAOYSA-N Dopaquinone Natural products OC(=O)C(N)CC1=CC(=O)C(=O)C=C1 AHMIDUVKSGCHAU-UHFFFAOYSA-N 0.000 description 1
- 208000004232 Enteritis Diseases 0.000 description 1
- 206010015150 Erythema Diseases 0.000 description 1
- 239000004386 Erythritol Substances 0.000 description 1
- UNXHWFMMPAWVPI-UHFFFAOYSA-N Erythritol Natural products OCC(O)C(O)CO UNXHWFMMPAWVPI-UHFFFAOYSA-N 0.000 description 1
- 208000010201 Exanthema Diseases 0.000 description 1
- 102000009123 Fibrin Human genes 0.000 description 1
- 108010073385 Fibrin Proteins 0.000 description 1
- BWGVNKXGVNDBDI-UHFFFAOYSA-N Fibrin monomer Chemical compound CNC(=O)CNC(=O)CN BWGVNKXGVNDBDI-UHFFFAOYSA-N 0.000 description 1
- 108090000270 Ficain Proteins 0.000 description 1
- 206010016952 Food poisoning Diseases 0.000 description 1
- 208000019331 Foodborne disease Diseases 0.000 description 1
- JUUHNUPNMCGYDT-UHFFFAOYSA-N Friedelin Natural products CC1CC2C(C)(CCC3(C)C4CC(C)(C)CCC4(C)CCC23C)C5CCC(=O)C(C)C15 JUUHNUPNMCGYDT-UHFFFAOYSA-N 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 240000008397 Ganoderma lucidum Species 0.000 description 1
- 235000001637 Ganoderma lucidum Nutrition 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 108010024636 Glutathione Proteins 0.000 description 1
- 240000002045 Guettarda speciosa Species 0.000 description 1
- 235000001287 Guettarda speciosa Nutrition 0.000 description 1
- 208000031226 Hyperlipidaemia Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- HCUARRIEZVDMPT-UHFFFAOYSA-N Indole-2-carboxylic acid Chemical compound C1=CC=C2NC(C(=O)O)=CC2=C1 HCUARRIEZVDMPT-UHFFFAOYSA-N 0.000 description 1
- AHMIDUVKSGCHAU-LURJTMIESA-N L-dopaquinone Chemical compound [O-]C(=O)[C@@H]([NH3+])CC1=CC(=O)C(=O)C=C1 AHMIDUVKSGCHAU-LURJTMIESA-N 0.000 description 1
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
- 102400000740 Melanocyte-stimulating hormone alpha Human genes 0.000 description 1
- 101710200814 Melanotropin alpha Proteins 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 229920000168 Microcrystalline cellulose Polymers 0.000 description 1
- 244000294411 Mirabilis expansa Species 0.000 description 1
- 235000015429 Mirabilis expansa Nutrition 0.000 description 1
- 239000004909 Moisturizer Substances 0.000 description 1
- 208000008589 Obesity Diseases 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- 229920002230 Pectic acid Polymers 0.000 description 1
- 244000082204 Phyllostachys viridis Species 0.000 description 1
- 235000015334 Phyllostachys viridis Nutrition 0.000 description 1
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 1
- 239000004952 Polyamide Substances 0.000 description 1
- 241000985694 Polypodiopsida Species 0.000 description 1
- 239000004365 Protease Substances 0.000 description 1
- 230000002292 Radical scavenging effect Effects 0.000 description 1
- 206010057190 Respiratory tract infections Diseases 0.000 description 1
- 241000722281 Saururus Species 0.000 description 1
- 241000534017 Saururus chinensis Species 0.000 description 1
- 244000000231 Sesamum indicum Species 0.000 description 1
- 235000003434 Sesamum indicum Nutrition 0.000 description 1
- 244000228451 Stevia rebaudiana Species 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- ULUAUXLGCMPNKK-UHFFFAOYSA-N Sulfobutanedioic acid Chemical compound OC(=O)CC(C(O)=O)S(O)(=O)=O ULUAUXLGCMPNKK-UHFFFAOYSA-N 0.000 description 1
- 229920001615 Tragacanth Polymers 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 1
- 230000005856 abnormality Effects 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 210000000577 adipose tissue Anatomy 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 235000013334 alcoholic beverage Nutrition 0.000 description 1
- 230000001476 alcoholic effect Effects 0.000 description 1
- 239000000783 alginic acid Substances 0.000 description 1
- 235000010443 alginic acid Nutrition 0.000 description 1
- 229920000615 alginic acid Polymers 0.000 description 1
- 229960001126 alginic acid Drugs 0.000 description 1
- 150000004781 alginic acids Chemical class 0.000 description 1
- JZVFJDZBLUFKCA-FXIAWGAOSA-N alpha-Spinasterol Chemical compound C1[C@@H](O)CC[C@]2(C)[C@@H](CC[C@@]3([C@@H]([C@H](C)/C=C/[C@@H](CC)C(C)C)CC[C@H]33)C)C3=CC[C@H]21 JZVFJDZBLUFKCA-FXIAWGAOSA-N 0.000 description 1
- JZVFJDZBLUFKCA-UTQQLQBSSA-N alpha-spinasterol Natural products CC[C@H](C=C[C@H](C)[C@H]1CC[C@H]2C3=CC[C@@H]4C[C@@H](O)CC[C@]4(C)[C@H]3CC[C@]12C)C(C)C JZVFJDZBLUFKCA-UTQQLQBSSA-N 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- WNROFYMDJYEPJX-UHFFFAOYSA-K aluminium hydroxide Chemical compound [OH-].[OH-].[OH-].[Al+3] WNROFYMDJYEPJX-UHFFFAOYSA-K 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 230000003579 anti-obesity Effects 0.000 description 1
- 230000003064 anti-oxidating effect Effects 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 208000011775 arteriosclerosis disease Diseases 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- 239000000605 aspartame Substances 0.000 description 1
- 235000010357 aspartame Nutrition 0.000 description 1
- IAOZJIPTCAWIRG-QWRGUYRKSA-N aspartame Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(=O)OC)CC1=CC=CC=C1 IAOZJIPTCAWIRG-QWRGUYRKSA-N 0.000 description 1
- 229960003438 aspartame Drugs 0.000 description 1
- OHDRQQURAXLVGJ-HLVWOLMTSA-N azane;(2e)-3-ethyl-2-[(e)-(3-ethyl-6-sulfo-1,3-benzothiazol-2-ylidene)hydrazinylidene]-1,3-benzothiazole-6-sulfonic acid Chemical compound [NH4+].[NH4+].S/1C2=CC(S([O-])(=O)=O)=CC=C2N(CC)C\1=N/N=C1/SC2=CC(S([O-])(=O)=O)=CC=C2N1CC OHDRQQURAXLVGJ-HLVWOLMTSA-N 0.000 description 1
- 239000011425 bamboo Substances 0.000 description 1
- 229960002903 benzyl benzoate Drugs 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 239000007844 bleaching agent Substances 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 235000008429 bread Nutrition 0.000 description 1
- HOWJQLVNDUGZBI-UHFFFAOYSA-N butane;propane Chemical compound CCC.CCCC HOWJQLVNDUGZBI-UHFFFAOYSA-N 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 239000000378 calcium silicate Substances 0.000 description 1
- 229910052918 calcium silicate Inorganic materials 0.000 description 1
- OYACROKNLOSFPA-UHFFFAOYSA-N calcium;dioxido(oxo)silane Chemical compound [Ca+2].[O-][Si]([O-])=O OYACROKNLOSFPA-UHFFFAOYSA-N 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 235000021466 carotenoid Nutrition 0.000 description 1
- 150000001747 carotenoids Chemical class 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 235000010980 cellulose Nutrition 0.000 description 1
- 235000013339 cereals Nutrition 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 235000019219 chocolate Nutrition 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 239000000084 colloidal system Substances 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 235000013365 dairy product Nutrition 0.000 description 1
- 235000019425 dextrin Nutrition 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 230000001079 digestive effect Effects 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- 150000002016 disaccharides Chemical class 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- VJNCICVKUHKIIV-UHFFFAOYSA-N dopachrome Chemical compound O=C1C(=O)C=C2NC(C(=O)O)CC2=C1 VJNCICVKUHKIIV-UHFFFAOYSA-N 0.000 description 1
- HHEAADYXPMHMCT-UHFFFAOYSA-N dpph Chemical compound [O-][N+](=O)C1=CC([N+](=O)[O-])=CC([N+]([O-])=O)=C1[N]N(C=1C=CC=CC=1)C1=CC=CC=C1 HHEAADYXPMHMCT-UHFFFAOYSA-N 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 239000003792 electrolyte Substances 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 231100000321 erythema Toxicity 0.000 description 1
- 235000019414 erythritol Nutrition 0.000 description 1
- 229940009714 erythritol Drugs 0.000 description 1
- UNXHWFMMPAWVPI-ZXZARUISSA-N erythritol Chemical compound OC[C@H](O)[C@H](O)CO UNXHWFMMPAWVPI-ZXZARUISSA-N 0.000 description 1
- 239000000686 essence Substances 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 201000005884 exanthem Diseases 0.000 description 1
- 229950003499 fibrin Drugs 0.000 description 1
- POTUGHMKJGOKRI-UHFFFAOYSA-N ficin Chemical compound FI=CI=N POTUGHMKJGOKRI-UHFFFAOYSA-N 0.000 description 1
- 235000019836 ficin Nutrition 0.000 description 1
- 239000006260 foam Substances 0.000 description 1
- 235000013373 food additive Nutrition 0.000 description 1
- 239000002778 food additive Substances 0.000 description 1
- 235000012041 food component Nutrition 0.000 description 1
- 230000009246 food effect Effects 0.000 description 1
- 239000005417 food ingredient Substances 0.000 description 1
- 230000037406 food intake Effects 0.000 description 1
- 238000009920 food preservation Methods 0.000 description 1
- 235000021022 fresh fruits Nutrition 0.000 description 1
- OFMXGFHWLZPCFL-SVRPQWSVSA-N friedelin Chemical compound C([C@H]1[C@]2(C)CC[C@@]34C)C(C)(C)CC[C@]1(C)CC[C@]2(C)[C@H]4CC[C@@]1(C)[C@H]3CCC(=O)[C@@H]1C OFMXGFHWLZPCFL-SVRPQWSVSA-N 0.000 description 1
- MFVJCHSUSSRHRH-UHFFFAOYSA-N friedeline Natural products CC1(C)CCC2(C)CCC3C4(C)CCC5C(C)(C)C(=O)CCC5(C)C4CCC3(C)C2C1 MFVJCHSUSSRHRH-UHFFFAOYSA-N 0.000 description 1
- 230000000855 fungicidal effect Effects 0.000 description 1
- 239000000417 fungicide Substances 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 229960003180 glutathione Drugs 0.000 description 1
- 239000008269 hand cream Substances 0.000 description 1
- 229960001340 histamine Drugs 0.000 description 1
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 1
- 235000015243 ice cream Nutrition 0.000 description 1
- MTNDZQHUAFNZQY-UHFFFAOYSA-N imidazoline Chemical class C1CN=CN1 MTNDZQHUAFNZQY-UHFFFAOYSA-N 0.000 description 1
- 230000001900 immune effect Effects 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 230000002757 inflammatory effect Effects 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 229940069445 licorice extract Drugs 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 230000003061 melanogenesis Effects 0.000 description 1
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 1
- 235000019813 microcrystalline cellulose Nutrition 0.000 description 1
- 239000008108 microcrystalline cellulose Substances 0.000 description 1
- 229940016286 microcrystalline cellulose Drugs 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 235000013536 miso Nutrition 0.000 description 1
- 230000001333 moisturizer Effects 0.000 description 1
- CQDGTJPVBWZJAZ-UHFFFAOYSA-N monoethyl carbonate Chemical compound CCOC(O)=O CQDGTJPVBWZJAZ-UHFFFAOYSA-N 0.000 description 1
- 150000002772 monosaccharides Chemical class 0.000 description 1
- 235000012149 noodles Nutrition 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 235000020824 obesity Nutrition 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 235000019198 oils Nutrition 0.000 description 1
- 229920001542 oligosaccharide Polymers 0.000 description 1
- 150000002482 oligosaccharides Chemical class 0.000 description 1
- 230000001590 oxidative effect Effects 0.000 description 1
- 229940094443 oxytocics prostaglandins Drugs 0.000 description 1
- 239000003002 pH adjusting agent Substances 0.000 description 1
- 239000012188 paraffin wax Substances 0.000 description 1
- LCLHHZYHLXDRQG-ZNKJPWOQSA-N pectic acid Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)O[C@H](C(O)=O)[C@@H]1OC1[C@H](O)[C@@H](O)[C@@H](OC2[C@@H]([C@@H](O)[C@@H](O)[C@H](O2)C(O)=O)O)[C@@H](C(O)=O)O1 LCLHHZYHLXDRQG-ZNKJPWOQSA-N 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- WVDDGKGOMKODPV-ZQBYOMGUSA-N phenyl(114C)methanol Chemical compound O[14CH2]C1=CC=CC=C1 WVDDGKGOMKODPV-ZQBYOMGUSA-N 0.000 description 1
- 239000003016 pheromone Substances 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 235000013550 pizza Nutrition 0.000 description 1
- 239000000419 plant extract Substances 0.000 description 1
- 229920002647 polyamide Polymers 0.000 description 1
- 239000010318 polygalacturonic acid Substances 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 150000004804 polysaccharides Chemical class 0.000 description 1
- 229920001296 polysiloxane Polymers 0.000 description 1
- 229920000136 polysorbate Polymers 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 239000003380 propellant Substances 0.000 description 1
- 150000003180 prostaglandins Chemical class 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 206010037844 rash Diseases 0.000 description 1
- HELXLJCILKEWJH-NCGAPWICSA-N rebaudioside A Chemical compound O([C@H]1[C@H](O)[C@@H](CO)O[C@H]([C@@H]1O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O HELXLJCILKEWJH-NCGAPWICSA-N 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- CVHZOJJKTDOEJC-UHFFFAOYSA-N saccharin Chemical compound C1=CC=C2C(=O)NS(=O)(=O)C2=C1 CVHZOJJKTDOEJC-UHFFFAOYSA-N 0.000 description 1
- 235000019204 saccharin Nutrition 0.000 description 1
- 229940081974 saccharin Drugs 0.000 description 1
- 239000000901 saccharin and its Na,K and Ca salt Substances 0.000 description 1
- 235000019643 salty taste Nutrition 0.000 description 1
- 239000012488 sample solution Substances 0.000 description 1
- 229940071089 sarcosinate Drugs 0.000 description 1
- FSYKKLYZXJSNPZ-UHFFFAOYSA-N sarcosine Chemical compound C[NH2+]CC([O-])=O FSYKKLYZXJSNPZ-UHFFFAOYSA-N 0.000 description 1
- 235000013580 sausages Nutrition 0.000 description 1
- HFHDHCJBZVLPGP-UHFFFAOYSA-N schardinger α-dextrin Chemical compound O1C(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(O)C2O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC2C(O)C(O)C1OC2CO HFHDHCJBZVLPGP-UHFFFAOYSA-N 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- 230000009759 skin aging Effects 0.000 description 1
- 235000011888 snacks Nutrition 0.000 description 1
- 239000000344 soap Substances 0.000 description 1
- 239000012064 sodium phosphate buffer Substances 0.000 description 1
- 229960002920 sorbitol Drugs 0.000 description 1
- 235000014347 soups Nutrition 0.000 description 1
- 235000013555 soy sauce Nutrition 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 235000000346 sugar Nutrition 0.000 description 1
- 230000000475 sunscreen effect Effects 0.000 description 1
- 239000000516 sunscreening agent Substances 0.000 description 1
- 239000000454 talc Substances 0.000 description 1
- 229910052623 talc Inorganic materials 0.000 description 1
- 229940124597 therapeutic agent Drugs 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 230000000451 tissue damage Effects 0.000 description 1
- 231100000827 tissue damage Toxicity 0.000 description 1
- 230000017423 tissue regeneration Effects 0.000 description 1
- 239000000196 tragacanth Substances 0.000 description 1
- 235000010487 tragacanth Nutrition 0.000 description 1
- 229940116362 tragacanth Drugs 0.000 description 1
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 239000001993 wax Substances 0.000 description 1
- 239000000811 xylitol Substances 0.000 description 1
- 235000010447 xylitol Nutrition 0.000 description 1
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 1
- 229960002675 xylitol Drugs 0.000 description 1
- WHNFPRLDDSXQCL-UAZQEYIDSA-N α-msh Chemical compound C([C@@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC=1NC=NC=1)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](C(C)C)C(N)=O)NC(=O)[C@H](CO)NC(C)=O)C1=CC=C(O)C=C1 WHNFPRLDDSXQCL-UAZQEYIDSA-N 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12J—VINEGAR; PREPARATION OR PURIFICATION THEREOF
- C12J1/00—Vinegar; Preparation or purification thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/36—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
- A23V2200/318—Foods, ingredients or supplements having a functional effect on health having an effect on skin health and hair or coat
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/02—Acid
- A23V2250/022—Acetic acid
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Organic Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Biochemistry (AREA)
- Wood Science & Technology (AREA)
- Birds (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Emergency Medicine (AREA)
- Epidemiology (AREA)
- Zoology (AREA)
- Botany (AREA)
- Mycology (AREA)
- Nutrition Science (AREA)
- Polymers & Plastics (AREA)
- Dermatology (AREA)
- Cosmetics (AREA)
Abstract
Description
본 발명은 무화과 발효물에 참취 에탄올 추출물 및 초산균을 접종하여 초산 발효하는 단계를 포함하여 제조하는 것을 특징으로 하는 피부 미백 효능이 증진된 식초의 제조방법, 상기 방법으로 제조된 피부 미백 효능이 증진된 식초 및 상기 식초를 유효성분으로 함유하는 피부 미백 개선용 건강기능식품 조성물에 관한 것이다.The present invention relates to a method for producing a vinegar having enhanced skin whitening efficacy, which comprises preparing a fermented product of fig and a fermented acetic acid by inoculating an ethanol extract of koji and acetic acid bacteria, Vinegar and vinegar as an active ingredient.
식초는 전통적으로 동서양을 막론하고 오랜 역사를 지닌 발효 식품으로 간장, 된장과 함께 우리 식생활과 밀접한 관련을 맺고 있는 중요한 조미료의 하나이다. 식초는 미생물을 이용하여 당류나 전분질을 함유하고 있는 여러 원료를 알코올 발효한 후 초산 발효하여 제조하는 원리이며, 신맛을 내는 초산성분을 비롯하여 25여 종의 유기산과 20여 종의 아미노산, 20여 종의 에테르 및 각종 영양물질이 함유된 복합 산미 조미료이자 건강식품이라 할 수 있다.Vinegar is traditionally a fermented food with a long history, both east and west, and it is one of the important seasonings that is closely related to our diet along with soy sauce and miso. Vinegar is the principle of fermentation of various raw materials containing saccharides and starches by fermentation with alcohol and then fermenting it with acetic acid. It contains 25 kinds of organic acids, 20 kinds of amino acids, 20 kinds Ether and a variety of nutrients containing a complex acidic seasoning and health food can be said.
식초는 식품 보존 효과뿐만 아니라 식품 방향제 또는 치료제로 널리 사용되고 있다. 일반적으로 식초는 음식물 자체의 맛을 좋게 할 뿐만 아니라 짠맛을 덜어주고 지방을 중화시켜 주는 작용을 한다. 또한, 식초는 피를 맑게 하며 피로 회복에 효과가 크고 각종 성인병을 치료하는데 좋은 원료로 널리 알려져 있다. 또한, 식초에 함유되어 있는 유기산과 아미노산 등은 질병에 대한 저항력을 높여 주고 위에서 흡수되어 산성체질을 개선하는 효과가 있다.Vinegar is widely used not only for food preservation but also as food fragrances or remedies. In general, vinegar not only improves the taste of the food itself, but also alleviates the salty taste and neutralizes the fat. Vinegar is also known as a good raw material for the treatment of various adult diseases, which cleanses the blood and is effective in restoring fatigue. In addition, the organic acids and amino acids contained in vinegar, such as increasing resistance to disease and absorbed from the above has the effect of improving the acidic constitution.
식초는 초산 이외의 각종 휘발성 및 비휘발성 유기산류, 당류, 아미노산류, 에스테르류를 함유하고 있어 식욕을 자극하는 방향과 맛을 가지며 생체 조직 내에서 쉽게 분해되어 다른 열량원보다 빠르게 칼로리를 발생하는 스테미너 식품으로 알려져 있다. 천연식초는 동맥경화, 고혈압 등의 성인병 예방효과, 식중독균의 살균효과, 콜레스테롤 저하효과, 체지방 감소 및 피로회복 효과 등에 관한 연구가 보고되면서 기능성 식품으로 인정되고 있고 다양한 용도로의 개발이 진행되고 있다. 또한, 천연식초는 우리 몸에 파로틴의 분비를 촉진하여 세포의 노화를 막고 뼈를 강하게 하고, 체내의 칼슘 흡착력을 높여 골의 질량을 늘리는 기능도 알려져 있다.Vinegar contains various volatile and nonvolatile organic acids, saccharides, amino acids and esters other than acetic acid. It has a direction and taste to stimulate the appetite and is easily decomposed in the living tissue to generate calories faster than other calorie sources. It is known as food. Natural vinegar has been recognized as a functional food and has been developed for a variety of uses as a result of studies on prevention of adult diseases such as arteriosclerosis and hypertension, sterilization effect of food poisoning bacteria, cholesterol lowering effect, reduction of body fat and fatigue recovery. In addition, the natural vinegar to promote the secretion of parotin in our body to prevent aging cells, strengthening the bones, increasing the body's calcium absorption capacity is known to increase the mass of the bone.
소득의 증가와 함께 건강한 삶을 위해 기능성 발효식품에 대한 수요가 급격히 증가하고 있다. 과일, 곡류, 산야초 등을 발효시켜 만든 식초는 초산을 비롯한 다양한 유기산, 아미노산 등의 기능성 성분이 풍부하여 만성질환의 예방, 면역력 증진 및 비만의 예방 등에 효과적인 것으로 알려져 있다.Demand for functional fermented foods is rapidly increasing for healthy living with increasing income. Vinegar made by fermenting fruits, grains, and hay fever is known to be effective in preventing chronic diseases, improving immunity, and preventing obesity because it is rich in functional ingredients such as various organic acids and amino acids including acetic acid.
최근에는 식초 음료 제품의 항비만 효능과 미백 효능, 향균활성을 기초로 슬리밍 기능과 피부미용 효능을 강조한 이너뷰티 컨셉의 뷰티푸드 및 기능성 화장품으로의 산업화 가능성이 기대되고 있다.In recent years, it is expected to be industrialized as a beauty food and a functional cosmetic of inner beauty concept that emphasizes slimming function and skin beauty effect based on anti-obesity effect, whitening effect, and antibacterial activity of vinegar drink products.
사람의 피부색을 결정하는 데는 여러 요인들이 관여하는데, 그 중에서도 멜라닌 색소를 만드는 멜라노사이트(melanocyte)의 활동성, 혈관의 분포, 피부의 두께 및 카로티노이드, 빌리루빈 등의 인체 내외의 색소 관련 요인들이 중요하다. 특히, 가장 중요한 요인은 인체 내의 멜라노사이트에서 타이로시나제 등의 여러 효소가 작용하여 생성되는 멜라닌이라는 색소이다. 피부의 색소침착은 자외선이나 염증 등의 자극에 의해 야기되며 또 유전적 요인이나 호르몬, 식품 등과 화학물질 등의 인자에 의해서도 발생된다고 알려져 있다. 특히 기미, 주근깨, 색소침착 등과 같은 피부색소 이상침착 증상에 프로스타글란딘(prostaglandins), 히스타민(histamine), 알파-MSH(alpha-MSH), NO(Nitric oxide) 같은 염증 관련 인자가 관여되어 멜라노사이트(melanocyte) 내에서 멜라닌 생성을 활성화시키는 것은 잘 알려져 있다. 또한, 조직의 손상과 재생과정에서도 면역학적 매개체에 의해 과색소 침착이 수반된다는 보고도 있다. Several factors are involved in determining the skin color of a person. Among them, the activity of melanocyte which makes melanin pigment, distribution of blood vessels, thickness of skin, carotenoid, bilirubin and other factors related to pigment are important. In particular, the most important factor is melanin, which is produced by the action of various enzymes such as tyrosinase in melanocytes in the human body. Skin pigmentation is caused by stimuli such as ultraviolet rays or inflammation, and it is also known to be caused by factors such as genetic factors, hormones, foods, and chemicals. In particular, inflammation related factors such as prostaglandins, histamine, alpha-MSH, and NO (nitric oxide) have been implicated in skin pigmentation abnormalities such as spots, freckles and pigmentation, and melanocytes ) Is known to activate melanin production. It is also reported that hyperpigmentation is accompanied by immunological mediators in the process of tissue damage and regeneration.
멜라닌 색소 합성을 구체적으로 살펴보면 멜라닌 세포(melanocytes)가 여러 요인에 의해 자극을 받으면 티로시나아제(tyrosinase)가 멜라노좀(melanosome)에서 멜라닌을 생성한다. 즉, 멜라닌 세포 내 티로신은 티로시나아제의 작용으로 도파(dopa)로 변하고, 이어 도파옥시다제(dopaoxidase)의 작용으로 도파퀴논(dopaquinone)으로 변한 후, 티로시나아제 관련 단백질-1(tyrosinase-related protein-1, 이하 TRP-1이라고 명기)과 티로시나아제 관련 단백질-2(tyrosinase-related protein-2, 이하 TRP-2이라고 명기)의 작용에 의하여 멜라닌을 생성한다. 이러한 일련의 반응에서 티로시나아제는 멜라닌 색소 형성 과정의 속도-제한 반응을 활성화시키므로, 멜라닌 형성은 티로시나아제의 활성 및 발현에 의하여 1차적으로 제어된다. 또한, DOPA 크롬 상호변이효소로 알려진 TRP-2는 DOPA 크롬의 5,6-디하이드록시인돌-2-카르복실산(DHICA)로의 반응을 활성화시키고, TRP-1는 DHICA를 카르복실 인돌-퀴논으로 산화시킨다. 결과적으로 TRP-1 및 TRP-2는 불용성 색소인 멜라닌 형성의 최종단계인 중합반응에 관여한다. 이들 티로시나아제(tyrosinase), TRP-1(tyrosinase-related protein-1), TRP-2(tyrosinase-related protein-2)는 염증 매개물질에 의해 활성이 증가되어 멜라닌의 합성이 증가된다는 보고가 있다.When melanocytes are stimulated by various factors, tyrosinase produces melanin in the melanosome. As a result, melanocytes are melanosomes. That is, tyrosine in melanocytes is transformed into dopa by the action of tyrosinase and then transformed into dopaquinone by the action of dopaoxidase, and then tyrosinase-related related protein-2 (hereinafter referred to as TRP-2) and tyrosinase-related protein-2 (hereinafter referred to as TRP-2) to produce melanin. In this series of reactions, tyrosinase activates the rate-limiting reaction of the melanin pigmentation process, so that melanogenesis is primarily controlled by the activity and expression of tyrosinase. TRP-2, also known as the DOPA chromium mutant enzyme, activates the reaction of DOPA chromium with 5,6-dihydroxyindole-2-carboxylic acid (DHICA), TRP-1 activates DHICA with carboxylindole- . As a result, TRP-1 and TRP-2 are involved in the polymerization reaction, which is the final stage of melanin formation, an insoluble pigment. It has been reported that tyrosinase, tyrosinase-related protein-1 (TRP-1) and tyrosinase-related protein-2 (TRP-2) are activated by inflammatory mediators to increase the synthesis of melanin .
현재 개발된 미백제로는 코지산, 알부틴, 글루타치온, 비타민 C 등이 있지만 소비자들이 만족할 만한 미백효과를 갖지 못하고 있으며, 피부 안전성 때문에 그 사용량이 제한적이다. 따라서 멜라닌 합성단계별로 다양한 시도가 이루어져 왔다.Currently developed whitening agents include kojic acid, arbutin, glutathione and vitamin C, but consumers do not have a satisfactory whitening effect and their use is limited due to skin safety. Thus, various attempts have been made to synthesize melanin.
무화과는 뽕나무과에 속하는 반교목성 과수로, 발진 및 궤양에 이용되어 왔으며 한방에서는 청열해독의 약리효능과 주독 및 어독 등의 치료제로 사용되어 왔다. 또한, 당질, 무기질 및 섬유소가 풍부하며 유용한 생리활성이 알려져 있으며, 피신(ficin)을 다량 함유하고 있어 육연화제로 이용되기도 한다. 또한, 민간요법에서는 변비개선 및 혈류개선 효능이 우수하다고 알려져 여성들에게 인기가 높다. 이러한 효능을 가지는 무화과가 저장성이 떨어져 주로 생과일로 사용되고 있다.The figs have been used for rashes and ulcers, and are used as therapeutic agents for the pharmacological efficacy of chrysanthemum detoxification and for the treatment of poisoning and ingestion. In addition, it is rich in carbohydrates, minerals, and fibrin, has a useful physiological activity, and contains a large amount of ficin, which is also used as a flavoring agent. In addition, folk remedies are known to be excellent for constipation improvement and blood flow improvement, which is popular among women. The figs with this effect are mainly used as fresh fruits because of their low storage stability.
참취(Aster scaber Thunb.)는 국화과의 여러해살이풀로 어린잎은 식용하며 성숙한 잎은 약용한다. 성분으로는 프리에델린(friedelin), α-스피나스테롤(α-spinasterol), 쿠마린(coumarin) 등을 함유하고 있고, 타박상과 독사교상을 치료하는데 사용하여 왔다. 참취는 미역취, 곰취 등과 같은 취나물에 속하며 이명은 취, 취나물, 동풍채라고 부른다. 참취가 속하는 취나물의 생산량은 약 12,267톤이며, 산과 들에서 자라며 한국, 일본, 중국 등지에 분포한다. 참동의학사전에 따르면 참취는 예로부터 해독제거, 혈액순환 촉진, 소화 장애, 장염으로 인한 복통 등에 효능이 있는 것으로 알려져 있다. 논문 및 특허에서는 항산화, 항고지혈, 항암, 피로회복 등의 연구가 진행되어 있다. Aster scaber Thunb. Is a perennial plant of Asteraceae. Its young leaves are edible and mature leaves are medicinal. Ingredients include friedelin, α-spinasterol, coumarin, etc., and have been used to treat bruises and poisonings. The ancestors are belonging to ferns such as seaweed, stinks, etc. The production of crab-like crabs is about 12,267 tons, growing in mountains and fields, and distributed in Korea, Japan, and China. According to the True Mind Science Dictionary, anger is known to be effective in detoxification, blood circulation promotion, digestive disorders, and colic due to enteritis. In the papers and patents, antioxidation, anti-hyperlipidemia, anticancer, and fatigue recovery are being studied.
한국등록특허 제1321611호에는 구절초 및 진주조개껍질을 함유하는 미백 효과를 갖는 기능성 식초의 제조방법이 개시되어 있고, 한국공개특허 제2013-0077911호에는 미백 효능을 가지는 죽순발효 식초의 제조방법이 개시되어 있으나, 본 발명의 참취 및 무화과를 이용한 피부 미백 효능이 증진된 식초와는 상이하다.Korean Patent Registration No. 1321611 discloses a method for producing a functional vinegar having a whitening effect, which comprises a perennial plant and a pearl shell. Korean Patent Laid-Open Publication No. 2013-0077911 discloses a method for producing a bamboo shoot fermented vinegar having whitening effect. However, the present invention is different from the vinegar in which the skin whitening effect using the chrysanthemum and figs of the present invention is enhanced.
본 발명은 상기와 같은 요구에 의해 안출된 것으로서, 본 발명자는 무화과 발효물에 참취 에탄올 추출물 및 초산균을 접종하여 초산 발효하여 제조된 식초가 피부 미백 개선 효과가 증진되는 것을 확인함으로써, 본 발명을 완성하였다.DISCLOSURE OF THE INVENTION The present invention has been made in view of the above-mentioned needs, and the present inventors have completed the present invention by confirming that the vinegar prepared by inoculating the fermented product of fig with ethanol extract and acetic acid and fermenting acetic acid enhances the skin whitening improvement effect Respectively.
상기 과제를 해결하기 위해, 본 발명은 (a) 참취에 에탄올을 첨가한 후 추출하여 참취 에탄올 추출물을 제조하는 단계; (b) 무화과 농축액에 사카로마이세스 세레비지애(Saccharomyces cerevisiae) 균주를 접종한 후 발효하는 단계; 및 (c) 상기 (b)단계의 발효한 발효물에 상기 (a)단계의 제조한 참취 에탄올 추출물 및 초산균을 접종하여 초산 발효하는 단계를 포함하여 제조하는 것을 특징으로 하는 피부 미백 효능이 증진된 식초의 제조방법을 제공한다.In order to solve the above-mentioned problems, the present invention provides a method for producing a flavored ethanol extract, comprising the steps of: (a) preparing a flavored ethanol extract by adding ethanol to a flavor; (b) In the concentrate of fig, Saccharomyces cerevisiae ) and then fermenting the same; And (c) fermenting the fermented fermented product of step (b) with acetic acid by inoculating the fermented product with the fermented product of step (a). The method according to claim 1, A method for producing vinegar is provided.
또한, 본 발명은 방법으로 제조된 피부 미백 효능이 증진된 식초를 제공한다.In addition, the present invention provides a vinegar having improved skin whitening efficacy prepared by the method.
또한, 본 발명은 상기 식초를 유효성분으로 함유하는 피부 미백 개선용 건강기능식품 조성물을 제공한다.The present invention also provides a health functional food composition for improving skin whitening comprising the vinegar as an active ingredient.
또한, 본 발명은 상기 식초를 유효성분으로 함유하는 피부 미백용 화장료 조성물을 제공한다.The present invention also provides a cosmetic composition for skin whitening comprising the vinegar as an active ingredient.
본 발명의 방법으로 제조된 식초는 폴리페놀 및 항산화 활성이 우수할 뿐만 아니라, 멜라닌 생성 및 티로시나아제 활성을 효과적으로 억제하여 피부 미백 효과가 증진되는 효과가 있다. 따라서, 본 발명의 식초를 피부 미백 개선을 위한 이너뷰티 제품으로 활용이 가능할 것으로 판단된다.The vinegar prepared by the method of the present invention is excellent in polyphenol and antioxidant activity, and effectively inhibits melanin production and tyrosinase activity, thereby enhancing skin whitening effect. Accordingly, it is considered that the vinegar of the present invention can be used as an inner beauty product for skin whitening improvement.
도 1은 식초의 농도별 피부 미백 효능을 검증하기 위한 티로시나아제 활성(A) 및 멜라닌 생합성량(B)을 분석한 그래프이다.FIG. 1 is a graph showing an analysis of tyrosinase activity (A) and melanin biosynthesis amount (B) for verifying skin whitening efficacy by vinegar concentration.
본 발명의 목적을 달성하기 위하여, 본 발명은In order to achieve the object of the present invention,
(a) 참취에 에탄올을 첨가한 후 추출하여 참취 에탄올 추출물을 제조하는 단계;(a) adding ethanol to a chrysanthemum and extracting it to prepare an ethanol extract of Chrysanthemum morifolium;
(b) 무화과 농축액에 사카로마이세스 세레비지애(Saccharomyces cerevisiae) 균주를 접종한 후 발효하는 단계; 및(b) In the concentrate of fig, Saccharomyces cerevisiae ) and then fermenting the same; And
(c) 상기 (b)단계의 발효한 발효물에 상기 (a)단계의 제조한 참취 에탄올 추출물 및 초산균을 접종하여 초산 발효하는 단계를 포함하여 제조하는 것을 특징으로 하는 피부 미백 효능이 증진된 식초의 제조방법을 제공한다.and (c) inoculating the fermented fermented product of step (b) with the fermented product of step (a) and acetic acid bacteria to ferment the fermented acetic acid. Of the present invention.
본 발명의 식초의 제조방법에서, 상기 (a)단계의 참취 에탄올 추출물은 바람직하게는 참취에 65~75%(v/v) 에탄올을 8~12배(v/w) 첨가한 후 1~3시간 동안 추출하여 제조할 수 있으며, 더욱 바람직하게는 참취에 70%(v/v) 에탄올을 10배(v/w) 첨가한 후 2시간 동안 추출하여 제조할 수 있다. 상기와 같이 제조된 참취 에탄올 추출물은 총 폴리페놀 함량 및 항산화 활성이 우수하여 품질이 우수한 식초 제조에 적합한 추출물로 제조할 수 있었다.In the method for producing vinegar of the present invention, the crude ethanol extract of step (a) is preferably prepared by adding 65 to 75% (v / v) ethanol to the anchovy to 8-12 times (v / w) (V / v) ethanol in an amount of 10 times (v / w) and then extracted for 2 hours. The crude ethanol extract prepared above had excellent total polyphenol content and antioxidant activity and could be produced as an extract suitable for producing vinegar having excellent quality.
또한, 본 발명의 식초의 제조방법에서, 상기 (c)단계에서 접종된 초산균은 바람직하게는 아세토박터 속(Acetobacter sp.)일 수 있으나, 이에 제한되지 않는다.In addition, in the method for producing vinegar of the present invention, the inoculated acetic acid bacteria in step (c) may be, but is not limited to, Acetobacter sp.
본 발명의 방법으로 제조된 식초는 멜라닌 생합성 및 티로시나아제 저해능이 우수하여, 피부 미백 효능을 나타내는 것을 특징으로 한다.The vinegar prepared by the method of the present invention is excellent in melanin biosynthesis and tyrosinase inhibiting ability, and is characterized by exhibiting skin whitening efficacy.
본 발명의 식초의 제조방법은, 보다 구체적으로는The method for producing vinegar of the present invention is more specifically
(a) 참취에 65~75%(v/v) 에탄올을 8~12배(v/w) 첨가한 후 1~3시간 동안 추출하여 참취 에탄올 추출물을 제조하는 단계;(a) adding 65 to 75% (v / v) ethanol to the anchovy by 8 to 12 times (v / w) and then extracting it for 1 to 3 hours to prepare an ethanol extract of the flavor;
(b) 무화과 농축액에 사카로마이세스 세레비지애(Saccharomyces cerevisiae) 균주를 접종한 후 28~32℃에서 3~5일 동안 발효하는 단계; 및(b) In the concentrate of fig, Saccharomyces cerevisiae ) and fermenting at 28 to 32 ° C for 3 to 5 days; And
(c) 상기 (b)단계의 발효한 발효물에 상기 (a)단계의 제조한 참취 에탄올 추출물 6~8%(v/v) 및 초산균을 접종하여 28~32℃에서 2~4일 동안 초산 발효하는 단계를 포함할 수 있으며,(c) 6 to 8% (v / v) of fermented ethanol extract prepared in step (a) and acetic acid bacteria are inoculated into the fermented fermented product of step (b) Fermentation step,
더욱 구체적으로는More specifically,
(a) 참취에 70%(v/v) 에탄올을 10배(v/w) 첨가한 후 2시간 동안 추출하여 참취 에탄올 추출물을 제조하는 단계;(a) adding 70% (v / v) ethanol 10 times (v / w) to the anchovy and then extracting it for 2 hours to prepare an ethanol extract of the flavor;
(b) 무화과 농축액에 사카로마이세스 세레비지애(Saccharomyces cerevisiae) 균주를 접종한 후 30℃에서 4일 동안 발효하는 단계; 및(b) In the concentrate of fig, Saccharomyces cerevisiae ), followed by fermentation at 30 DEG C for 4 days; And
(c) 상기 (b)단계의 발효한 발효물에 상기 (a)단계의 제조한 참취 에탄올 추출물 7%(v/v) 및 초산균을 접종하여 30℃에서 3일 동안 초산 발효하는 단계를 포함할 수 있다.(c) inoculating fermented fermented product of step (b) with 7% (v / v) of fermented ethanol extract prepared in step (a) and fermenting acetic acid for 3 days at 30 ° C .
본 발명은 또한, 상기 방법으로 제조된 피부 미백 효능이 증진된 식초를 제공한다.The present invention also provides a vinegar with enhanced skin whitening efficacy, prepared by the above method.
본 발명은 또한, 상기 식초를 유효성분으로 함유하는 멜라닌 색소 과다 침착 질환의 개선용 건강기능식품 조성물을 제공한다.The present invention also provides a health functional food composition for improving melanin pigment hyperpigmentation diseases containing the vinegar as an active ingredient.
상기 멜라닌 색소 과다 침착 질환은 주근깨, 노인성 반점, 간반, 기미, 갈색 또는 흑점, 일광 색소반, 푸른흑피증(cyanic melasma), 약물 사용 후의 과다 색소 침착, 찰상, 화상 또는 피부염으로 인한 염증 후 과다 색소 침착 또는 임신성 갈색반(gravidic chloasma)일 수 있으나, 이에 제한되지 않는다.The melanin pigment hyperpigmentation disorder is a hyperpigmentation disorder caused by inflammation caused by freckles, senile spots, liver, spots, brown or black spots, daylight pigmentation, cyanic melasma, hyperpigmentation after drug use, scratches, burns or dermatitis Or a gravidic chloasma. ≪ / RTI >
본 발명의 건강기능식품 조성물을 식품첨가물로 사용하는 경우, 상기 건강기능식품 조성물을 그대로 첨가하거나 다른 식품 또는 식품성분과 함께 사용될 수 있고, 통상적인 방법에 따라 적절하게 사용될 수 있다. 유효성분의 양은 그의 사용 목적(예방 또는 개선)에 따라 적절하게 사용될 수 있다. 일반적으로, 식품 또는 음료의 제조시 본 발명의 건강기능식품 조성물은 원료에 대하여 15 중량부 이하, 바람직하게는 10 중량부 이하의 양으로 첨가된다. 그러나 건강을 목적으로 하는 장기간의 섭취인 경우에는 상기 양은 상기 범위 이하일 수 있으며, 안전성 면에서 아무런 문제가 없기 때문에 유효성분은 상기 범위 이상의 양으로 사용될 수 있다.When the health functional food composition of the present invention is used as a food additive, the health functional food composition may be added as it is, or may be used together with other food or food ingredients, and suitably used according to a conventional method. The amount of the active ingredient can be suitably used depending on its use purpose (prevention or improvement). Generally, the health functional food composition of the present invention is added in an amount of not more than 15 parts by weight, preferably not more than 10 parts by weight based on the raw material, when the food or beverage is produced. However, in the case of long-term consumption intended for health, the amount may be less than the above range, and since there is no problem in terms of safety, the active ingredient may be used in an amount of more than the above range.
상기 건강기능식품의 종류에 특별한 제한은 없다. 상기 건강기능식품 조성물을 첨가할 수 있는 식품의 예로는 육류, 소시지, 빵, 초콜릿, 캔디류, 스낵류, 과자류, 피자, 라면, 기타 면류, 껌류, 아이스크림류를 포함한 낙농제품, 각종 스프, 음료수, 차 드링크제, 알코올음료 및 비타민 복합제 등이 있으며, 통상적인 의미에서의 건강식품을 모두 포함한다.There is no particular limitation on the kind of the health functional food. Examples of the foods to which the health functional food composition can be added include dairy products including meat, sausage, bread, chocolate, candy, snacks, confectionery, pizza, ramen and other noodles, gums, ice cream, soups, Alcoholic beverages, and vitamin complexes, all of which include health foods in a conventional sense.
또한, 본 발명의 건강기능식품 조성물은 식품, 특히 기능성 식품으로 제조될 수 있다. 본 발명의 기능성 식품은 식품 제조 시에 통상적으로 첨가되는 성분을 포함하며, 예를 들어, 단백질, 탄수화물, 지방, 영양소 및 조미제를 포함한다. 예컨대, 드링크제로 제조되는 경우에는 유효성분 이외에 천연 탄수화물 또는 향미제를 추가 성분으로서 포함시킬 수 있다. 상기 천연 탄수화물은 모노사카라이드(예컨대, 글루코오스, 프럭토오스 등), 디사카라이드(예컨대, 말토스, 수크로오스 등), 올리고당, 폴리사카라이드(예컨대, 덱스트린, 시클로덱스트린 등) 또는 당알코올(예컨대, 자일리톨, 소르비톨, 에리쓰리톨 등)인 것이 바람직하다. 상기 향미제는 천연 향미제(예컨대, 타우마틴, 스테비아 추출물 등)와 합성 향미제(예컨대, 사카린, 아스파르탐 등)를 이용할 수 있다.In addition, the health functional food composition of the present invention can be produced as a food, particularly a functional food. The functional food of the present invention includes components that are ordinarily added in food production, and includes, for example, proteins, carbohydrates, fats, nutrients, and seasonings. For example, in the case of a drink, a natural carbohydrate or a flavoring agent may be included as an additional ingredient in addition to the active ingredient. The natural carbohydrate may be selected from the group consisting of monosaccharides (e.g., glucose, fructose, etc.), disaccharides (e.g., maltose, sucrose etc.), oligosaccharides, polysaccharides (e.g., dextrin, cyclodextrin, , Xylitol, sorbitol, erythritol, etc.). The flavoring agent may be a natural flavoring agent (e.g., tau Martin, stevia extract, etc.) and a synthetic flavoring agent (e.g., saccharin, aspartame, etc.).
상기 건강기능식품 조성물 이외에 여러 가지 영양제, 비타민, 전해질, 풍미제, 착색제, 펙트산 및 그의 염, 알긴산 및 그의 염, 유기산, 보호성 콜로이드 증점제, pH 조절제, 안정화제, 방부제, 글리세린, 알코올, 탄산음료에 사용되는 탄산화제 등을 더 함유할 수 있다. 이러한 상기 첨가되는 성분의 비율은 크게 중요하진 않지만 본 발명의 건강기능식품 조성물 100 중량부에 대하여, 0.01 내지 0.1 중량부의 범위에서 선택되는 것이 일반적이다.In addition to the health functional food composition, it is also possible to use various nutrients, vitamins, electrolytes, flavors, colorants, pectic acid and salts thereof, alginic acid and its salts, organic acids, protective colloid thickening agents, pH adjusting agents, stabilizers, preservatives, glycerin, A carbonating agent used in beverages, and the like. Although the ratio of the above-mentioned ingredients is not critical, it is generally selected in the range of 0.01 to 0.1 part by weight based on 100 parts by weight of the health functional food composition of the present invention.
본 발명은 또한, 상기 식초를 유효성분으로 함유하는 피부 미백용 화장료 조성물을 제공한다.The present invention also provides a cosmetic composition for skin whitening comprising the vinegar as an active ingredient.
본 발명에서, 피부 미백효과란, 자외선 노출, 호르몬 밸런스의 변화, 유전적 프로그램 등의 각종 요인에 의해 발생하는 거뭇한 피부나 기미, 주근깨, 다크서클을 개선 또는 방지하는 효과, 피부를 투명감 있는 아름다운 것으로 하는, 혹은 투명감 있는 아름다운 피부를 유지하는 효과, 피부의 칙칙함을 경감하여 윤기ㆍ팽팽함을 증가시키는 효과 등을 의도하고 있다. 일반적으로, 거뭇한 피부나 기미, 주근깨, 다크서클은 자외선에 의한 자극이나 호르몬 밸런스의 변화 등에 의해 멜라노사이트(melanocyte)가 자극되고, 이로 인해 생합성된 멜라닌 색소가 피부에 침착하여 발생한다고 알려져 있다. 따라서, 멜라닌의 생성을 억제할 수 있다면, 거뭇한 피부나 기미, 주근깨, 다크서클을 예방ㆍ개선하는 것이 가능하다.In the present invention, the skin whitening effect is an effect of improving or preventing glaring skin, spots, freckles and dark circles caused by various factors such as exposure to ultraviolet rays, change in hormone balance, genetic program, etc., Or an effect of maintaining a beautiful skin with a sense of transparency and an effect of reducing the dullness of the skin to increase gloss and tautness. Generally, it is known that the skin, spots, freckles, and dark circles are stimulated by melanocytes due to stimulation by ultraviolet rays or changes in hormone balance, and melanin pigment that is biosynthesized thereby is deposited on the skin. Therefore, if the production of melanin can be inhibited, it is possible to prevent or improve gross skin, spots, freckles and dark circles.
본 발명의 일 구현 예에 따른 화장료 조성물에 있어서, 상기 피부 미백용 화장료 조성물은 스킨, 스킨 소프트너, 스킨 토너, 로션, 밀크로션, 모이스쳐로션, 영양로션, 마사지크림, 영양크림, 아이크림, 모이스쳐크림, 핸드크림, 에센스, 영양에센스, 팩, 클렌징폼, 클렌징워터, 클렌징크림, 바디로션, 바디클렌져, 비누 및 파우더 중에서 선택된 어느 하나의 제형을 가질 수 있으나, 이에 제한되지 않는다. 이들 각 제형으로 이루어진 화장료 조성물은 그 제형의 제제화에 필요하고 적절한 각종의 기제와 첨가물을 함유할 수 있으며, 이들 성분의 종류와 양은 당업자에 의해 용이하게 선정될 수 있다. In the cosmetic composition according to one embodiment of the present invention, the skin whitening cosmetic composition may be at least one selected from the group consisting of skin, skin softener, skin toner, lotion, milk lotion, But are not limited to, any one form of cream, hand cream, essence, nutrition essence, pack, cleansing foam, cleansing water, cleansing cream, body lotion, body cleanser, soap and powder. The cosmetic composition comprising each of these formulations may contain various bases and additives necessary for formulation of the formulation, and the kinds and amounts of these ingredients can be easily selected by those skilled in the art.
본 발명의 화장료 조성물은 유효성분 이외에 추가로 동일 또는 유사한 기능을 나타내는 피부 미백 활성 성분을 1종 이상 함유할 수 있다. 피부 미백 활성 성분으로는 코지산 및 이의 유도체, 알부틴, 아스코르브산 및 이의 유도체, 하이드로퀴논 및 이의 유도체, 레조르시놀, 사이클로알카논, 메틸렌디옥시페닐 알칸올, 2,7-디니트로인다졸 또는 덩굴귤 추출물, 쌀 추출물, 감초 추출물과 같은 식물 추출물 등이 있으나, 이에 제한되는 것은 아니다.The cosmetic composition of the present invention may contain, in addition to the active ingredient, at least one skin whitening active ingredient exhibiting the same or similar functions. Skin whitening active ingredients include kojic acid and its derivatives, arbutin, ascorbic acid and its derivatives, hydroquinone and its derivatives, resorcinol, cycloalkanone, methylenedioxyphenylalkanol, 2,7-dinitroindazole or Plant extracts such as mandarin orange extract, rice extract, licorice extract, and the like, but are not limited thereto.
본 발명의 화장료 조성물의 제형이 페이스트, 크림 또는 겔인 경우에는 담체 성분으로서 동물섬유, 식물섬유, 왁스, 파라핀, 전분, 트라가칸트, 셀룰로오스 유도체, 폴리에틸렌 글리콜, 실리콘, 벤토나이트, 실리카, 탈크 또는 산화아연 등이 이용될 수 있다.When the formulation of the cosmetic composition of the present invention is a paste, a cream or a gel, an animal fiber, a plant fiber, a wax, a paraffin, a starch, a tragacanth, a cellulose derivative, a polyethylene glycol, a silicone, a bentonite, Etc. may be used.
본 발명의 화장료 조성물의 제형이 파우더 또는 스프레이인 경우에는 담체 성분으로서 락토스, 탈크, 실리카, 알루미늄 히드록시드, 칼슘 실리케이트 또는 폴리아미드 파우더가 이용될 수 있고, 특히 스프레이인 경우에는 추가적으로 클로로플루오로히드로카본, 프로판-부탄 또는 디메틸 에테르와 같은 추진체를 포함할 수 있다.When the formulation of the cosmetic composition of the present invention is a powder or a spray, lactose, talc, silica, aluminum hydroxide, calcium silicate or polyamide powder may be used as a carrier component. Especially, in the case of a spray, Propellants such as carbon, propane-butane or dimethyl ether.
본 발명의 화장료 조성물의 제형이 용액 또는 유탁액인 경우에는 담체 성분으로서 용매, 용매화제 또는 유탁화제가 이용되고, 예컨대 물, 에탄올, 이소프로판올, 에틸 카보네이트, 에틸 아세테이트, 벤질 알코올, 벤질 벤조에이트, 프로필렌글리콜, 1,3-부틸글리콜 오일, 글리세롤 지방족 에스테르, 폴리에틸렌 글리콜 또는 소르비탄의 지방산 에스테르가 있다.When the formulation of the cosmetic composition of the present invention is a solution or an emulsion, a solvent, a solvent or an emulsifier is used as a carrier component, and examples thereof include water, ethanol, isopropanol, ethyl carbonate, ethyl acetate, benzyl alcohol, benzyl benzoate, Glycol, 1,3-butyl glycol oil, glycerol aliphatic ester, polyethylene glycol or fatty acid esters of sorbitan.
본 발명의 화장료 조성물의 제형이 현탁액인 경우에는 담체 성분으로서 물, 에탄올 또는 프로필렌 글리콜과 같은 액상 희석제, 에톡실화 이소스테아릴 알코올, 폴리옥시에틸렌 소르비톨 에스테르 및 폴리옥시에틸렌 소르비탄 에스테르와 같은 현탁제, 미소결정성 셀룰로오스, 알루미늄 메타히드록시드, 벤토나이트, 아가 또는 트라칸트 등이 이용될 수 있다.When the formulation of the cosmetic composition of the present invention is a suspension, a carrier such as water, a liquid diluent such as ethanol or propylene glycol, a suspension such as ethoxylated isostearyl alcohol, polyoxyethylene sorbitol ester and polyoxyethylene sorbitan ester, Microcrystalline cellulose, aluminum metahydroxide, bentonite, agar or tracant, etc. may be used.
본 발명의 화장료 조성물의 제형이 계면-활성제 함유 클렌징인 경우에는 담체 성분으로서 지방족 알코올 설페이트, 지방족 알코올 에테르설페이트, 설포숙신산 모노에스테르, 아세티오네이트, 이미다졸리늄 유도체, 메틸타우레이트, 사르코시네이트, 지방산 아미드 에테르 설페이트, 알킬아미도베타인, 지방족 알코올, 지방산 글리세리드, 지방산 디에탄올아미드, 식물성 유, 리놀린 유도체 또는 에톡실화 글리세롤 지방산 에스테르 등이 이용될 수 있다.When the formulation of the cosmetic composition of the present invention is an interfacial-active agent-containing cleansing, the carrier component may include aliphatic alcohol sulfate, aliphatic alcohol ether sulfate, sulfosuccinic acid monoester, acethionate, imidazolinium derivative, methyltaurate, sarcosinate , Fatty acid amide ether sulfate, alkylamidobetaine, aliphatic alcohol, fatty acid glyceride, fatty acid diethanolamide, vegetable oil, linolenic derivative or ethoxylated glycerol fatty acid ester.
본 발명의 화장료 조성물은 형광물질, 살진균제, 굴수성 유발물질, 보습제, 방향제, 방향제 담체, 단백질, 용해화제, 당 유도체, 일광차단제, 비타민, 식물 추출물 등을 포함하는 부형제를 추가로 함유할 수 있다.The cosmetic composition of the present invention may further contain an excipient including a fluorescent substance, a fungicide, a hygroscopic substance, a moisturizer, a fragrance, a fragrance carrier, a protein, a solubilizer, a sugar derivative, a sunscreen, a vitamin, .
이하, 본 발명의 제조예 및 실시예를 들어 상세히 설명한다. 단, 하기 제조예 및 실시예는 본 발명을 예시하는 것일 뿐, 본 발명의 내용이 하기 제조예 및 실시예에 한정되는 것은 아니다.Hereinafter, production examples and examples of the present invention will be described in detail. However, the following Preparation Examples and Examples are illustrative of the present invention, and the content of the present invention is not limited to the following Production Examples and Examples.
제조예Manufacturing example 1. One. 참취Anger +무화과 식초 제조+ Fig and vinegar manufacturing
1) 참취 에탄올 추출물 제조1) Preparation of ethanol extract
건조한 후 분쇄한 참취 3 g에 70%(v/v) 에탄올을 30 mL을 넣고, 상온에서 180 rpm으로 2시간 동안 교반하여 추출한 후, 3,000 rpm에서 10분 동안 원심 분리한 뒤 0.2 ㎛ 필터로 여과하여 참취 에탄올 추출물을 제조하였다.After drying, 30 g of 70% (v / v) ethanol was added to 3 g of crushed sesame seeds, and the mixture was stirred at 180 rpm for 2 hours at room temperature. The mixture was centrifuged at 3,000 rpm for 10 minutes, To prepare an ethanol extract of Chrysanthemum morifolium.
2) 무화과 초산 발효 식초 제조2) Production of fig and acetic acid fermented vinegar
65 brix의 무화과 농축액을 배지에 10% 첨가한 후, 사카로마이세스 세레비지애(Saccharomyces cerevisiae) 균주를 접종한 후 30℃에서 96시간 동안 알코올 발효하였다. 상기 알코올 발효한 발효물에 상기 1)에서 제조한 참취 에탄올 추출물을 7% 첨가한 후, 초산 균주인 아세토박터 속(Acetobacter sp.)을 접종하여 30℃에서 180 rpm으로 72시간 배양하여 초산 발효하였다. 발효된 초산 발효액은 12,000 rpm에서 15분 동안 원심 분리한 뒤 여과하여 시료로 사용하였다.After adding 65% brix of the fig concentrate to the medium at 10%, saccharomyces cerevisiae S. cerevisiae ) and then fermented at 30 ° C. for 96 hours. To the alcoholic fermented fermented product, 7% of the crude ethanol extract prepared in 1) above was added, and then the mixture was incubated with an Acetobacter sp.) and incubated at 30 ° C for 180 hours at 180 rpm for acetic acid fermentation. The fermented acetic acid fermentation broth was centrifuged at 12,000 rpm for 15 minutes and filtered to use as a sample.
비교예Comparative Example 1. 무화과 식초 제조 1. Manufacture of fig and vinegar
상기 제조예 1의 방법으로 식초를 제조하되, 1)에서 참취 대신 무화과를 사용하여 제조한 무화과 에탄올 추출물을 이용하여 식초를 제조하였다.Vinegar was prepared by the method of Preparation Example 1, using the ethanol extract of figs prepared in 1), instead of the anchovy, using the figs.
비교예Comparative Example 2. 2. 참취Anger 식초 제조 Vinegar manufacturing
상기 제조예 1의 방법으로 식초를 제조하되, 2)에서 무화과 대신 참취를 사용한 알코올 발효물을 이용하여 식초를 제조하였다.Vinegar was prepared in the same manner as in Preparation Example 1, except that vinegar was prepared in 2) using an alcohol fermentation product instead of figs.
비교예Comparative Example 3. 3. 참취Anger +삼백초+당귀+무화과 식초 제조+ Saururus chinensis + Angelica + fig and vinegar production
상기 제조예 1의 방법으로 식초를 제조하되, 1)에서 참취 3 g 대신 참취 1 g, 삼백초 1 g 및 당귀 1 g을 사용하여 제조한 에탄올 추출물을 이용하여 식초를 제조하였다.Vinegar was prepared in the same manner as in Preparation Example 1 except that ethanol extract prepared by using 1 g, 3 g of Saururus, and 1 g of Ganoderma lucidum instead of 3 g of anchovy was used in 1).
비교예Comparative Example 4. 4. 참취Anger +무화과 식초 제조+ Fig and vinegar manufacturing
상기 제조예 1의 방법으로 식초를 제조하되, 1)에서 참취 대신 무화과를 사용하여 제조한 무화과 에탄올 추출물과 2)에서 무화과 대신 참취를 사용한 알코올 발효물을 이용하여 식초를 제조하였다.Vinegar was prepared from the fig and ethanol extracts prepared by using figs instead of anchovies in 1), and alcohol fermented with anodes in place of figs in 2) to prepare vinegar by the method of Preparation Example 1 above.
실시예Example 1. One. 참취Anger 추출물의 추출 수율, 총 폴리페놀 함량 및 The extraction yield, total polyphenol content and 항산화능Antioxidant ability 측정 Measure
참취 물 추출물과 제조예 1의 1)단계에서 제조된 참취 에탄올 추출물을 가지고 추출 수율, 폴리페놀 함량 및 항산화 활성을 측정한 결과는 하기 표 1과 같다. 참취 물 추출물은 건조한 후 분쇄한 참취 3 g에 물 30 mL을 넣고 100℃에서 2시간 동안 추출한 후, 3,000 rpm에서 10분 동안 원심 분리한 뒤 0.2 ㎛ 필터로 여과하여 참취 물 추출물을 제조하였다.The extract yield, polyphenol content, and antioxidative activity of the water extract of Chrysanthemum indicum and the crude chrysanthemum extract prepared in step 1) of Preparation Example 1 were measured and the results are shown in Table 1 below. After drying, 30 g of water was added to 3 g of crushed anchovy, and the mixture was extracted at 100 ° C. for 2 hours, centrifuged at 3,000 rpm for 10 minutes, and filtered through a 0.2 μm filter to prepare a water extract.
그 결과, 추출 수율은 참취 물 추출물이 참취 에탄올 추출물에 비해 좀 더 높게 나타났으나, 총 폴리페놀 함량 및 항산화 활성은 참취 에탄올 추출물이 더 높은 수치를 나타내었다.As a result, the extraction yields were higher than those of the ethanol extracts, but the total polyphenol contents and antioxidant activities of the ethanol extracts were higher than those of the ethanol extracts.
실시예Example 2. 식초의2. Vinegar 미백 효능 평가 Whitening efficacy evaluation
멜라닌(Melanin) 생합성 측정은 B16F10 세포를 12 웰(well)에 0.5×105 cells/mL이 되도록 접종하여 배양하고, 24시간 뒤 각 웰(well)에 추출물(0.05, 0.1, 0.2 mg/mL)과 알부틴(100 ㎍/mL)을 48시간 동안 처리하였다. 처리 후 PBS(phosphate buffered saline)로 2회 세척한 후 원심 분리하여 세포 침전물을 만들었다. 10% DMSO(dimethyl sulfoxide)가 첨가된 1N NaOH 용액을 200 ㎕ 첨가하고 80℃에서 1시간 용해하였으며 405 nm에서 흡광도를 측정하였다.Melanin biosynthesis was performed by inoculating B16F10 cells into 12 wells at a concentration of 0.5 × 10 5 cells / mL. After 24 hours, extracts (0.05, 0.1, 0.2 mg / mL) were added to each well, And arbutin (100 [mu] g / mL) for 48 hours. After the treatment, the cells were washed twice with PBS (phosphate buffered saline) and centrifuged to make cell precipitate. 200 ㎕ of 1 N NaOH solution containing 10% DMSO (dimethyl sulfoxide) was added and dissolved at 80 캜 for 1 hour and absorbance was measured at 405 nm.
티로시나아제(Tyrosinase) 저해 활성 측정으로 반응구 0.1M 인산나트륨 완충액(pH 6.8) 1 mL에 10 mM L-DOPA(L-3,4-dihydroxypheny-lalanine)를 녹인 기질액 140 ㎕ 및 추출물 60 ㎕의 혼합액을 37℃에서 1시간 반응시켜 반응액 중에 생성된 DOPA chrome을 490 nm에서 측정하였다. 티로시나아제(Tyrosinase) 저해 활성은 시료용액의 첨가구와 무첨가구의 흡광도 감소율로 나타내었다.To measure tyrosinase inhibitory activity, 140 μl of a substrate solution in which 10 mM L-DOPA (L-3,4-dihydroxypheny-lalanine) was dissolved in 1 ml of a 0.1 M sodium phosphate buffer solution (pH 6.8) and 60 μl Was reacted at 37 ° C for 1 hour, and the DOPA chrome produced in the reaction solution was measured at 490 nm. Tyrosinase inhibitory activity was expressed by the absorbance reduction rate of the sample solution and the non-added sample.
피부는 자외선에 노출되면 티로시나아제(Tyrosinase)에서 출발하여 일련에 산화 중합반응을 거쳐 생성된 멜라닌에 의해 기미, 노인성 홍반 등을 유발하며 피부 노화가 촉진된다. 이 과정에서 중요하게 작용하는 효소가 티로시나아제(tyrosinase)이며, 티로시나아제(tyrosinase) 효소의 억제는 멜라닌 생합성을 억제할 수 있는 것으로 알려져 있다. When skin is exposed to ultraviolet rays, it starts from tyrosinase, and after a series of oxidative polymerization reaction, melanin generated by skin causes spots and age-related erythema and promotes skin aging. The enzyme that plays an important role in this process is tyrosinase, and inhibition of tyrosinase enzyme is known to inhibit melanin biosynthesis.
제조예 1의 참취+무화과 식초와 비교예 1의 무화과 식초를 가지고 미백 효과를 평가한 결과는 도 1과 같다. 그 결과, 식초 처리로 멜라닌 생성을 억제하고 티로시나아제 억제 활성이 있는 것을 확인하였고, 특히 무화과 식초에 비해 참취+무화과 식초가 멜라닌 및 티로시나아제 억제 활성이 더 우수한 것으로 나타났다(도 1).Fig. 1 shows the result of evaluating the whitening effect with the flavor + fig vinegar of Preparation Example 1 and the fig vinegar of Comparative Example 1. Fig. As a result, it was confirmed that vinegar treatment inhibited melanin production and inhibited tyrosinase inhibition. Especially, pheromone vinegar + fig vinegar showed better melanin and tyrosinase inhibitory activity than fig vinegar (FIG. 1).
실시예Example 3: 식초의 관능검사 3: Sensory evaluation of vinegar
제조예 1과 비교예들의 식초를 가지고 5점 평점법으로 관능검사를 실시하였다. 관능검사는 20세 이상의 직장인 30명을 대상으로 식초를 기호에 맞게 물과 희석하여 시음하게 한 후 향, 맛 및 전체적인 기호도에 대한 관능검사를 3회 반복 실시한 후 그 결과를 평균하여 아래 표 2에 나타내었다.The vinegar of Preparation Example 1 and Comparative Example was subjected to sensory evaluation by the 5-point scale method. The sensory evaluation was carried out on 30 workers who were over 20 years old. The vinegar was tasted by diluting with water to taste, and then the sensory evaluation of flavor, taste and overall taste was repeated 3 times, and the results were averaged. Respectively.
그 결과, 향, 맛 및 전체적인 기호도에서 제조예 1의 식초가 가장 높은 점수를 나타내어, 제조예 1의 조건으로 식초를 제조하는 것이 가장 바람직함을 확인할 수 있었다.As a result, it was confirmed that the vinegar of Preparation Example 1 showed the highest score in flavor, taste, and overall taste, and that vinegar was most preferably prepared under the conditions of Preparation Example 1.
Claims (5)
(b) 무화과 농축액에 사카로마이세스 세레비지애(Saccharomyces cerevisiae) 균주를 접종한 후 발효하는 단계; 및
(c) 상기 (b)단계의 발효한 발효물에 상기 (a)단계의 제조한 참취 에탄올 추출물 및 초산균을 접종하여 초산 발효하는 단계를 포함하여 제조하는 것을 특징으로 하는 피부 미백 효능이 증진된 식초의 제조방법.(a) adding ethanol to a chrysanthemum and extracting it to prepare an ethanol extract of Chrysanthemum morifolium;
(b) In the concentrate of fig, Saccharomyces cerevisiae ) and then fermenting the same; And
and (c) inoculating the fermented fermented product of step (b) with the fermented product of step (a) and acetic acid bacteria to ferment the fermented acetic acid. ≪ / RTI >
(a) 참취에 65~75%(v/v) 에탄올을 8~12배(v/w) 첨가한 후 1~3시간 동안 추출하여 참취 에탄올 추출물을 제조하는 단계;
(b) 무화과 농축액에 사카로마이세스 세레비지애(Saccharomyces cerevisiae) 균주를 접종한 후 28~32℃에서 3~5일 동안 발효하는 단계; 및
(c) 상기 (b)단계의 발효한 발효물에 상기 (a)단계의 제조한 참취 에탄올 추출물 6~8%(v/v) 및 초산균을 접종하여 28~32℃에서 2~4일 동안 초산 발효하는 단계를 포함하여 제조하는 것을 특징으로 하는 피부 미백 효능이 증진된 식초의 제조방법.The method of claim 1, wherein
(a) adding 65 to 75% (v / v) ethanol to the anchovy by 8 to 12 times (v / w) and then extracting it for 1 to 3 hours to prepare an ethanol extract of the flavor;
(b) In the concentrate of fig, Saccharomyces cerevisiae ) and fermenting at 28 to 32 ° C for 3 to 5 days; And
(c) 6 to 8% (v / v) of fermented ethanol extract prepared in step (a) and acetic acid bacteria are inoculated into the fermented fermented product of step (b) And a fermenting step, wherein the skin whitening effect is enhanced.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020170173232 | 2017-12-15 | ||
KR20170173232 | 2017-12-15 |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20190072445A true KR20190072445A (en) | 2019-06-25 |
KR102149177B1 KR102149177B1 (en) | 2020-08-28 |
Family
ID=67065279
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020180160518A KR102149177B1 (en) | 2017-12-15 | 2018-12-13 | Vinegar with enhanced skin whitening effect using Aster scaber and Ficus carica and production method thereof |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR102149177B1 (en) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2021050166A (en) * | 2019-09-26 | 2021-04-01 | 学校法人中部大学 | Tyrosinase activity reduction agent |
KR20210076725A (en) * | 2019-12-16 | 2021-06-24 | 한국콜마주식회사 | Moisturizing composition comprising aster scaber extract, ligularia fischeri extract and allium monathum extract as an effective ingredient |
KR102281861B1 (en) * | 2020-12-02 | 2021-07-26 | 김지형 | A method for preparing a cosmetic composition comprising fermented product of fig alcohol extract and the cosmetic composition prepared therefrom |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20030069500A (en) * | 2002-02-20 | 2003-08-27 | 윤광심 | The preparation of fermentation Fig-vinegar using korean drug agent and fig fruit |
KR100767626B1 (en) * | 2006-09-20 | 2007-10-17 | 사단법인미래산업기술연구원 | Processes for preparing fermented fig vinegars and fermented fig vinegars prepared thereby |
-
2018
- 2018-12-13 KR KR1020180160518A patent/KR102149177B1/en active IP Right Grant
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20030069500A (en) * | 2002-02-20 | 2003-08-27 | 윤광심 | The preparation of fermentation Fig-vinegar using korean drug agent and fig fruit |
KR100767626B1 (en) * | 2006-09-20 | 2007-10-17 | 사단법인미래산업기술연구원 | Processes for preparing fermented fig vinegars and fermented fig vinegars prepared thereby |
Non-Patent Citations (1)
Title |
---|
이은호 외 8명. 참취 추출물의 생리활성. 한국식품저장유통학회지. 23(3): 393~401(2016)* * |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2021050166A (en) * | 2019-09-26 | 2021-04-01 | 学校法人中部大学 | Tyrosinase activity reduction agent |
KR20210076725A (en) * | 2019-12-16 | 2021-06-24 | 한국콜마주식회사 | Moisturizing composition comprising aster scaber extract, ligularia fischeri extract and allium monathum extract as an effective ingredient |
KR102281861B1 (en) * | 2020-12-02 | 2021-07-26 | 김지형 | A method for preparing a cosmetic composition comprising fermented product of fig alcohol extract and the cosmetic composition prepared therefrom |
WO2022119074A1 (en) * | 2020-12-02 | 2022-06-09 | 김지형 | Method for preparing cosmetic composition comprising fermented fig alcohol extract, and cosmetic composition prepared thereby |
Also Published As
Publication number | Publication date |
---|---|
KR102149177B1 (en) | 2020-08-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR101743200B1 (en) | Composition for skin whitening comprising fraction of fruit extract of Sageretia thea as effective component | |
KR101937331B1 (en) | Vinegar with enhanced anti-obesity, anti-inflammatory and skin whitening effect using Mapleleaf ainsliaea and manufacturing method thereof | |
KR102149177B1 (en) | Vinegar with enhanced skin whitening effect using Aster scaber and Ficus carica and production method thereof | |
WO2019124862A1 (en) | Skin wrinkle prevention and improvement composition containing schisandra chinensis extract as active ingredient | |
KR101453258B1 (en) | Health Functional Food Composition Comprising Red Ginseng Extract, Benincasa Hispida Extract, and Apios Americana Extract for Improving Skin Beauty | |
KR101943976B1 (en) | Composition for skin whitening comprising Capsicum annuum seed extract as effective component | |
KR20140068679A (en) | Composition comprising extracts of white tea for the care of skin wrinkle | |
KR101907919B1 (en) | Composition for preventing or improving skin wrinkle comprising Siraitia grosvenori residual extract as effective component | |
KR102016994B1 (en) | Pepper leaf extreact with improved skin whitening effect and manufacturing method thereof | |
KR102035188B1 (en) | Composition for skin whitening comprising Cacalia firma extract as effective component | |
KR101858118B1 (en) | Composition for skin whitening comprising fermented Geomgangsong as effective component | |
KR101832169B1 (en) | Composition for skin whitening comprising extract of Picrasma quassioides as effective component | |
KR101761142B1 (en) | Skin-lightening Composition Using an Extract of Rumex acetosella | |
KR101931269B1 (en) | Composition for skin whitening comprising extract of roasted Alpinia katsumadai semen as effective component | |
KR102198871B1 (en) | Composition for skin whitening comprising Cacalia firma extract produced by enzyme treatment as effective component | |
KR102549076B1 (en) | Composition for skin whitening comprising mixture of fermented ginseng leaf extract and Miscanthus sinensis extract as effective component | |
KR102515649B1 (en) | Cosmetic composition for skin whitening and anti-wrinkle comprising extract of steamed Polygonatum sibiricum as effective componenet | |
KR102105897B1 (en) | Skin whitening composition comprising Ainsliaea acerifolia extract produced by ultra high pressure homogenization as effective component | |
KR102468186B1 (en) | Composition for Skin-lightening Using an Extract of Lotus corniculatus var. japonica | |
KR102374364B1 (en) | Skin-lightening Composition Using an Extract of Eleocharis ussuriensis | |
KR102018643B1 (en) | Composition for skin whitening comprising pepper leaf extract produced by enzyme treatment and ultra high pressure homogenization as effective component | |
KR102239470B1 (en) | Composition for skin whitening comprising extract of fermented black rice with improved antioxidant activity as effective component | |
KR20120050059A (en) | Composition for skin wrinkle improvement and whitening comprising extracts of coriandum sativum. l as an active ingredient | |
KR101867350B1 (en) | Skin-lightening Composition Using an Extract of Enzyme Treatments of Wood-cultivated Ginseng Seeds | |
KR20170046028A (en) | Composition for whitening containing extract of unripe fruit |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant |